MissionIR Articles

Fusion Telecommunications International, Inc. (NASDAQ: FSNN),in concert with its subsidiaries, provides cloud communications, cloud connectivity, cloud computing, and managed cloud-based solutions to small, medium, and large businesses worldwide. The company also offers voice services to…

Global Blood Therapeutics, Inc. (NASDAQ: GBT) is a clinical stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. GBT is developing its initial product…

FlexShopper, Inc. (OTC: FPAY) provides a flexible and easy way for consumer to get furniture, electronics, appliances and other popular brand name goods through low, affordable weekly payments. The company’s goal is to get customers…

The biotechnology company Flex Pharma, Inc. (NASDAQ: FLKS) is developing innovative and proprietary treatments for exercise-associated muscle cramps, nocturnal leg cramps, and spasms associated with severe neuromuscular conditions. Flex Pharma’s products will be designed to…

Finjan Holdings, Inc. (NASDAQ: FNJN) offers investors a diversified and unique vehicle for investing in cybersecurity-related intellectual property-backed technologies under the guidance of a proven team. Finjan’s commitment to innovation in the security space continues…

Fate Therapeutics, Inc. (NASDAQ: FATE) is a clinical‑stage biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life‑threatening diseases. The company is primarily focused on developing programmed hematopoietic cellular…

Eyegate Pharmaceuticals, Inc. (OTC: EYEG), a late-stage specialty pharmaceutical and drug delivery company, is working on developing and commercializing therapeutics and drug delivery mechanisms for treating eye diseases. The company’s technology addresses two of the…

EuroSite Power, Inc. (OTC: EUSP) is a majority-owned subsidiary of American DG Energy, and has been established to expand its successful on-site utility business into the United Kingdom and Europe. The company sells the energy…

Energy Fuels, Inc. (NYSE: UUUU) is America’s premier integrated uranium miner. Uranium is the fuel for nuclear, which is the true “green energy” as it provides emission-free and carbon-free electricity. Energy Fuels is positioned as…

Emisphere Technologies, Inc. (EMIS) is a specialty pharmaceutical company that recently commenced commercial operations. The company launched its first prescription product, oral Eligen B12, in the U.S. in March 2015. Beyond Eligen B12, the company…

Emisphere Technologies, Inc. (OTCBB: EMIS), a commercial stage, specialty pharmaceutical company, is currently preparing to launch its first prescription product, oral Eligen B12, in the United States. Beyond Eligen B12, the company employs its proprietary…

eMagin Corporation (NYSE: EMAN) is a leading manufacturer of active-matrix Organic LED (AM-OLED) microdisplays on silicon. These displays perform at low-power levels, extended temperature ranges and provide image performance not possible with LCD technologies. The…

Elite Pharmaceuticals, Inc. (OTCQB: ELTP) is a specialty pharmaceutical companydeveloping a pipeline of proprietary pharmacological abuse-deterrent opioid products and niche generic products. Elite specializes in oral sustained and controlled release drug products with high barriers…

Echo Therapeutics, Inc. (NASDAQ: ECTE) is changing the blood glucose monitoring industry. The company has successfully demonstrated the ability to continuously monitor blood glucose non-invasively in healthy, Type I, Type II and hospital patients. Echo’s…

Biopharmaceutical company DURECT Corporation (NASDAQ: DRRX) has expertise in drug discovery, delivery and development, applying those skills primarily to therapeutics in the fields of pain management, CNS disorders, acute organ injury and metabolic diseases. The…

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) is a late stage pharmaceutical company focused on developing and selling Locilex (pexiganan cream 0.8%), a potent and broad spectrum topical antibiotic peptide, for the treatment of mild and moderate…

DiaMedica, Inc. (OTCQB: DMCAF) is a biopharmaceutical company focused on developing innovative treatments for stroke and other vascular diseases where no current therapies are available. The company is preparing to advance its proprietary recombinant form…

DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) is a clinical and commercial stage drug development company with a focus on the treatment of cancer. The company is in the midst of conducting clinical trials in the U.S.…

Delcath Systems, Inc. (NASDAQ: DCTH) is a specialty pharmaceutical and medical device company focused on oncology and, more specifically, the treatment of primary and metastatic liver cancers. The company’s proprietary product – Melphalan Hydrochloride for…

DBV Technologies S.A. (NASDAQ: DBVT) is committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments. The company has a proprietary platform…